NASDAQ · SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE · MID CAP
Lifemd, Inc. LFMD
14 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$194.1M
▲ 25.3% vs FY2024
EPS · FY25
$0.25
Dividend / sh · FY25
—
Payout · FY25
22%
ROE · FY25
204.0%
Net margin · FY25
7.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 194.1M
Revenue, FY2025 · full 14-year series below
Revenue
Net income
7 cents of every revenue dollar became profit this year.
Per share
USD 0.25
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
204.0%
Return on equity, FY2025
ROE
Operating margin-4.0%
Net margin7.4%
Return on assets19.6%
Each USD of equity produced 204 cents of profit this year.
Returned to shareholders
USD 3.1M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 3.1M
Net buybacksUSD -8.5M
Share of profit21.6%
Consecutive raises—
USD 3.1M in dividends — 22% of the year's profit went back to shareholders.
Growth
+39.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+17.7%
+39.1%
+66.0%
Returned to shareholders
+0.0%
+76.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.05B
Shares outstanding, FY2025
Change, 5 years+100.0%
Change, 10 years—
The share count grew 100% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 70.4M
total assets, end of FY2025
Total assetsUSD 70.4M
EquityUSD 23.2M
CashUSD 36.8M
Current ratio1.25×
Equity funds 33% of total assets.
History
14 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Revenue $B
0.2
0.2
0.2
0.1
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
−0.0
−0.0
−0.0
−0.1
·
·
·
·
·
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
·
·
·
·
·
·
Net income $B
0.0
−0.0
−0.0
−0.0
−0.1
−0.1
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
0.25
−0.60
·
·
·
·
·
·
−0.03
−0.03
0.00
−0.02
−0.01
−0.02
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
22
−15
−15
−7
−1
·
·
·
·
·
−17
·
·
·
ROE %
204.0
·
·
−802.8
−595.9
·
·
−139.4
−457.9
·
·
−1644.9
−162.3
−330.1
Shares out B
0.05
0.04
0.04
0.03
0.03
0.02
0.01
0.05
0.04
0.04
0.03
0.03
0.03
0.03
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
49 of 49
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed